BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rattis BAC, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19. Front Pharmacol 2021;12:675287. [PMID: 34025433 DOI: 10.3389/fphar.2021.675287] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Kow CS, Ramachandram DS, Hasan SS. The effect of curcumin on the risk of mortality in patients with COVID-19: A systematic review and meta-analysis of randomized trials. Phytother Res 2022. [PMID: 35484795 DOI: 10.1002/ptr.7468] [Reference Citation Analysis]
2 Sagulkoo P, Suratanee A, Plaimas K. Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. Biomolecules 2022;12:690. [DOI: 10.3390/biom12050690] [Reference Citation Analysis]
3 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
4 Atiyah NA, Albayati TM, Atiya MA. Functionalization of mesoporous MCM-41 for the delivery of curcumin as an anti-inflammatory therapy. Advanced Powder Technology 2022. [DOI: 10.1016/j.apt.2021.103417] [Reference Citation Analysis]
5 Peng Y, Ao M, Dong B, Jiang Y, Yu L, Chen Z, Hu C, Xu R. Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. Drug Des Devel Ther 2021;15:4503-25. [PMID: 34754179 DOI: 10.2147/DDDT.S327378] [Reference Citation Analysis]
6 Fu Y, Ho W, Kang N, Tsai M, Wu J, Huang L, Weng C. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Front Pharmacol 2022;13:863082. [DOI: 10.3389/fphar.2022.863082] [Reference Citation Analysis]
7 Singh R, Bhardwaj VK, Purohit R. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach. Comput Biol Med 2021;139:104965. [PMID: 34717229 DOI: 10.1016/j.compbiomed.2021.104965] [Reference Citation Analysis]
8 Ebob OT, Babiaka SB, Ntie-Kang F. Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2. Nat Prod Bioprospect 2021. [PMID: 34515981 DOI: 10.1007/s13659-021-00317-w] [Reference Citation Analysis]
9 Jannat K, Paul AK, Bondhon TA, Hasan A, Nawaz M, Jahan R, Mahboob T, Nissapatorn V, Wilairatana P, Pereira ML, Rahmatullah M. Nanotechnology Applications of Flavonoids for Viral Diseases. Pharmaceutics 2021;13:1895. [PMID: 34834309 DOI: 10.3390/pharmaceutics13111895] [Reference Citation Analysis]